FDA Inspection 736481 — Carter BloodCare

Carter BloodCare — FEI 3002603147

The FDA completed an inspection of Carter BloodCare on July 27, 2011 in Bedford, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 27, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bedford, TX (United States)

Citations

IDCFRDescription
20721 CFR 640.3(a)Donor suitability not performed on day of collection
20821 CFR 640.3(a)(1)Donor suitability procedures not followed
29121 CFR 640.56(d)Potency level - corrective action
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
9821 CFR 606.100(c)Thorough investigations